TAAR1 Agonism for Psychosis
What do we know about the efficacy, adverse events, and mechanisms of a new class of medications (called “Trace Amine Associated Receptor 1 agonists” or “TAAR1 agonists”) in treating psychosis?
Latest Research Reports
Who we are?
A new living evidence resource of early phase research for research prioritisation in mental health.
It’s difficult for researchers, funders, people with lived experience, and others with an interest in mental health science to keep track of the ever-expanding literature. How can this information, which is published every day, all over the world, be gathered, analysed, and used effectively to design new research that makes a difference?
Our Partners
What is an ontology?
An ontology is a formal representation of knowledge or information about a particular domain. It is a structured way of organising and categorising information, concepts and relationships within a specific subject area.
News & Blog
08 Sep. 2023
Announcing the Global Experiential Advisory Board – GLEAB
The number of research publications is increasing every day, in all scientific areas including mental health. This makes it increasingly more challenging for academics, health professionals and members of the public to read through all the new public...
08 Mar. 2023
Experts Share Their Excitement at the First GALENOS Meeting
The Global Alliance for Living Evidence on aNxiety, depressiOn and pSychosis, or GALENOS project, launched today in central London. The meeting, which was attended by 35 people from around the globe w...
09 Jun. 2023
GALENOS in the BMJ
Today the British Medical Journal shared their perspective on GALENOS. The article explains why this new systematic review of available literature was needed, and how it might accelerate research into...
12 Oct. 2023
Pro-dopaminergic pharmacological interventions for anhedonia in depression: protocol for a living systematic
Depression is a complex mental health condition affecting millions worldwide. One of its most debilitating symptoms is anhedonia, characterized by a lack of interest or pleasure in previously enjoyabl...
05 Jul. 2023
Research Appreciation Day
This Wednesday the 5th of July is the inaugural 'Research Appreciation Day', a social media initiative to celebrate and recognise the ground-breaking work of health researchers.
09 Feb. 2024
TAAR1 Agonism for Psychosis
What do we know about the efficacy, adverse events, and mechanisms of a new class of medications (called “Trace Amine Associated Receptor 1 agonists” or “TAAR1 agonists”) in treating psychosis? To ans...
09 Oct. 2023
Trace Amine-Associated Receptor 1 Agonists For Psychosis: Protocol For A Living Systematic Review
Psychotic disorders affect around 1% of the population, and rank among the top 20 causes of disability worldwide.
Explore Opportunities with Galenos
Galenos possesses an extensive repository of research and data pertaining to anxiety, depression, and psychosis. Have a question or want to learn more? We’d love to hear from you!